EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Gut microbiota shifts and short‐chain fatty acids alterations in pediatric epilepsy patients on a Mediterranean ketogenic diet

Sofia Zouganeli iD, Evdokia K Mitsou, Mary Yannakoulia iD, Evangelia Intze, Konstantinos C Mountzouris, Smaragdi Fessatou, Achilleas Attilakos, Adamantini Kyriacou, Argyrios Dinopoulos

Epileptic Disorders · 2026-08 · 28 (4) · 1159-1174

DOI: 10.1002/epd2.70269 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Epileptic Disorders, online erschienen am 07.05.2026. Verfasst von Sofia Zouganeli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, General University Hospital Attikon, Athens, Greece. Hauptthemen laut MEDLINE: Diet, Ketogenic, Diet, Mediterranean, Drug Resistant Epilepsy, Fatty Acids, Volatile. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: DANONE NUTRICIA GREECE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The olive oil–based Mediterranean ketogenic diet (MedKD) may support patients with drug‐resistant epilepsy (DRE) or neurometabolic disorders by integrating ketogenic therapy with the cardiometabolic and neuroprotective advantages of the Mediterranean diet. This study assessed alterations in gut microbiota composition and short‐chain fatty acids (SCFAs) in Greek pediatric epilepsy patients under a 3‐month MedKD.

Methods

Patients eligible for ketogenic diet therapy and one parent per patient as controls were enrolled. An olive oil–based KD aligned with Mediterranean principles was initiated during a 5–7‐day hospital stay. Anthropometric, nutritional, biochemical and clinical data were recorded at baseline and after 3 months. Fecal samples were collected from patients at both time points, and parents provided a single baseline sample. Microbiota composition was analyzed using 16S rRNA gene next‐generation sequencing, and SCFAs were quantified via gas chromatography. Written informed consent was obtained from all parents. The study was registered at ClinicalTrials.gov (NCT05898438).

Results

The study enrolled 18 pediatric/adolescent patients (aged 2.5–15.5 years) and 17 parents at baseline (T1). After 3 months (T2), 13 patient–parent pairs completed follow‐up. MedKD adherence was high, with mean ketone levels of 2.6 mmol/L and a clinical response in 85% of patients. Anthropometric measurements improved, and lipid changes were modest. No significant α‐diversity differences were detected between patients and parents at T1 or between T1 and T2 in patients, whereas β‐diversity differed significantly between parents and patients at baseline. Epilepsy‐associated genera were more abundant in patients. At T2, patients exhibited shifts including increased members of Eggerthellaceae and decreased Lachnospira and Bifidobacterium . Major SCFAs remained stable, with increases limited to minor protein‐derived SCFAs. Significance The MedKD was associated with high adherence, efficacy, and anthropometric improvements, along with modest effects on the lipid profile. Microbial and SCFA changes reflected both the epilepsy‐related milieu and potential influences of the diet's high olive oil content.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, KetogenicDiet, MediterraneanDrug Resistant EpilepsyFatty Acids, VolatileGastrointestinal MicrobiomeAdolescentChildChild, PreschoolFemaleHumansMale

Stichwörter der Autor:innen

MediterraneanSCFAsepilepsyketogenicmicrobiotapediatric

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Clinical Nutrition, General University Hospital Attikon, Athens, Greece.
  • Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.
  • Department of Clinical Microbiology, School of Medicine, University of Crete, Heraklion, Greece.
  • Department of Nutritional Physiology and Feeding, Agricultural University of Athens, Athens, Greece.
  • Third Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens, General University Hospital Attikon, Athens, Greece.

ORCID-Profile: Sofia Zouganeli, Mary Yannakoulia

Förderung

  • DANONE NUTRICIA GREECE

Zitieren

APA

Zouganeli, S., Mitsou, E. K., Yannakoulia, M., Intze, E., Mountzouris, K. C., Fessatou, S., Attilakos, A., Kyriacou, A., & Dinopoulos, A. (2026). Gut microbiota shifts and short‐chain fatty acids alterations in pediatric epilepsy patients on a Mediterranean ketogenic diet. Epileptic Disorders, 28(4), 1159-1174. https://doi.org/10.1002/epd2.70269

Vancouver

Zouganeli S, Mitsou EK, Yannakoulia M, Intze E, Mountzouris KC, Fessatou S, et al. Gut microbiota shifts and short‐chain fatty acids alterations in pediatric epilepsy patients on a Mediterranean ketogenic diet. Epileptic Disorders. 2026;28(4):1159-1174. doi:10.1002/epd2.70269

BibTeX
@article{Zouganeli2026,
  author = {Zouganeli, Sofia and Mitsou, Evdokia K and Yannakoulia, Mary and Intze, Evangelia and Mountzouris, Konstantinos C and Fessatou, Smaragdi and Attilakos, Achilleas and Kyriacou, Adamantini and Dinopoulos, Argyrios},
  title = {Gut microbiota shifts and short‐chain fatty acids alterations in pediatric epilepsy patients on a Mediterranean ketogenic diet},
  journal = {Epileptic Disorders},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {1159--1174},
  doi = {10.1002/epd2.70269}
}
Kostenlos starten →